Vascular Access
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Butterfly NetworkCA - Palo Alto
1 programbi-plane sonographic view to difficult peripheral vascular access using Butterfly iQ+®N/A1 trial
Active Trials
Butterfly BiosciencesCA - Marina del Rey
1 programbi-plane sonographic view to difficult peripheral vascular access using Butterfly iQ+®N/A
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
PerceptiveVu-Path™
Butterfly Networkbi-plane sonographic view to difficult peripheral vascular access using Butterfly iQ+®
Clinical Trials (2)
Total enrollment: 442 patients across 2 trials
A Percutaneous Ultrasound Device With Needle Guide for Vascular Access
Start: Sep 2026Est. completion: Dec 20280
N/AWithdrawn
NCT05119673Butterfly Networkbi-plane sonographic view to difficult peripheral vascular access using Butterfly iQ+®
POCUS for Difficult Peripheral Access in the Emergency Department - a RCT
Start: Oct 2021Est. completion: May 2022442 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.